Searched for: in-biosketch:true
person:romw01
Pulmonary Embolism Severity Index In Patients With Acute Pulmonary Embolism After Orthopedic Surgery [Meeting Abstract]
Uppal, A.; Steiger, D.; Abi-Fadel, D.; Shreve, M.; Reid, M.; Rom, W. N.; Dweck, E.
ISI:000208771001136
ISSN: 1073-449x
CID: 4136252
In-hospital Pulmonary Embolism Mortality In Orthopedic Surgical Patients [Meeting Abstract]
Abi-Fadel, D.; Uppal, A.; Dweck, E.; Bashar, M.; Bonura, E.; Reid, M.; Rom, W.; Steiger, D.
ISI:000208771001134
ISSN: 1073-449x
CID: 4136242
Traditional Urban Pollution
Chapter by: Parsia, S; Patrawalla, A; Rom, WN
in: Occupational and Environmental Lung Diseases by
pp. 405-419
ISBN:
CID: 841492
Molecular analysis of plasma DNA for the early detection of lung cancer by quantitative methylation-specific PCR
Ostrow, Kimberly Laskie; Hoque, Mohammad O; Loyo, Myriam; Brait, Marianna; Greenberg, Alissa; Siegfried, Jill M; Grandis, Jennifer R; Gaither Davis, Autumn; Bigbee, William L; Rom, William; Sidransky, David
PURPOSE: Aberrant promoter hypermethylation of tumor suppressor genes is a promising marker for lung cancer detection. We investigated the likelihood of detecting aberrant DNA methylation of tumor suppressor genes in plasma samples of patients with abnormalities of the lung detected upon computed tomography (CT) scan. EXPERIMENTAL DESIGN: In a small evaluation cohort, four gene promoters (DCC, Kif1a, NISCH, and Rarb) were found to be methylated with increased frequency in samples from cancer patients specifically. We then examined DNA from 93 plasma samples from patients with abnormal findings in the lung detected upon CT scan for aberrant methylation of these four gene promoters by quantitative fluorogenic real-time PCR. The patients were divided into two groups, ground glass opacity (n = 23) and cancerous tumors (n = 70). Plasma DNA from age-matched nodule-free individuals were used as controls (n = 80). RESULTS: In plasma, 73% of patients with cancerous tumors showed methylation of at least one gene with a specificity of 71% (P = 0.0001). Only 22% patients with ground glass opacity exhibited methylation of at least one gene. When smoking history was taken into account, 72% of cancer patients with no smoking history or those who smoked <20 pack-years showed methylation of at least one gene with 100% specificity (P = 0.05) when compared with matched controls. Among heavy smokers with 20+ pack-years of smoking history, 30% of the control group and 73% of the patients with cancerous tumors showed methylation (P = 0.0001). CONCLUSIONS: These biomarkers can distinguish between cancerous and noncancerous abnormal CT findings.
PMCID:2899894
PMID: 20592015
ISSN: 1078-0432
CID: 302862
Emerging exposures and respiratory health: world trade center dust
Rom, William N; Reibman, Joan; Rogers, Linda; Weiden, Michael D; Oppenheimer, Beno; Berger, Kenneth; Goldring, Roberta; Harrison, Denise; Prezant, David
The attack on the World Trade Center (WTC) on 9/11/2001 produced a massive dust cloud with acute exposure, and the rubble pile burning over 3 months exposed more than 300,000 residents, rescue workers, and clean-up workers. Firefighters in the New York City Fire Department had significant respiratory symptoms characterized by cough, dyspnea, gastroesophageal reflux, and nasal stuffiness with a significant 1-year decline in FVC and FEV(1). Bronchial hyperreactivity measured by methacholine challenge correlated with bronchial wall thickening on CT scans. Compared with the NHANES III data for FVC and FEV(1), 32% of 2,000 WTC dust-exposed residents and clean-up workers were below the lower 5th percentile. The most common abnormality was a low FVC pattern, a finding similar to that also described for individuals in rescue and recovery activities. Among those complaining of respiratory symptoms and normal spirometry, almost half had abnormalities detected with impedance oscillometry consistent with distal airways' disease. Follow-up with the WTC Health Registry and the WTC Environmental Health Center will help discern whether treatment with anti-inflammatory medications or bronchodilators in those with respiratory symptoms may prevent the development of chronic obstructive pulmonary disease
PMCID:3266022
PMID: 20427588
ISSN: 1943-5665
CID: 109531
UNLOCKING BIOMARKER DISCOVERY FOR EARLY DETECTION OF LUNG CANCER [Meeting Abstract]
Ostroff, R.; Bigbee, W.; Franklin, W.; Gold, L.; Mehan, M.; Miller, Y.; Pass, H.; Rom, W.; Siegfried, J.; Stewart, A.; Walker, J.; Weissfeld, J.; Williams, S.; Zichi, D.; Brody, E.
ISI:000290390500031
ISSN: 1010-4283
CID: 132750
Identification of an autoantibody panel to separate lung cancer from smokers and nonsmokers
Rom, William N; Goldberg, Judith D; Addrizzo-Harris, Doreen; Watson, Heather N; Khilkin, Michael; Greenberg, Alissa K; Naidich, David P; Crawford, Bernard; Eylers, Ellen; Liu, Daorong; Tan, Eng M
BACKGROUND: Sera from lung cancer patients contain autoantibodies that react with tumor associated antigens (TAAs) that reflect genetic over-expression, mutation, or other anomalies of cell cycle, growth, signaling, and metabolism pathways. METHODS: We performed immunoassays to detect autoantibodies to ten tumor associated antigens (TAAs) selected on the basis of previous studies showing that they had preferential specificity for certain cancers. Sera examined were from lung cancer patients (22); smokers with ground-glass opacities (GGOs) (46), benign solid nodules (55), or normal CTs (35); and normal non-smokers (36). Logistic regression models based on the antibody biomarker levels among the high risk and lung cancer groups were developed to identify the combinations of biomarkers that predict lung cancer in these cohorts. RESULTS: Statistically significant differences in the distributions of each of the biomarkers were identified among all five groups. Using Receiver Operating Characteristic (ROC) curves based on age, c-myc, Cyclin A, Cyclin B1, Cyclin D1, CDK2, and survivin, we obtained a sensitivity = 81% and specificity = 97% for the classification of cancer vs smokers(no nodules, solid nodules, or GGO) and correctly predicted 31/36 healthy controls as noncancer. CONCLUSION: A pattern of autoantibody reactivity to TAAs may distinguish patients with lung cancer versus smokers with normal CTs, stable solid nodules, ground glass opacities, or normal healthy never smokers
PMCID:2885364
PMID: 20504322
ISSN: 1471-2407
CID: 110098
Does asbestos exposure (asbestosis) cause (clinical) airway obstruction (small airway disease)? [Editorial]
Miller, Albert; Rom, William N
PMID: 20713640
ISSN: 1535-4970
CID: 133824
WTC PM2.5 stimulates a more intense inflammatory response in human BAL cells than other ambient PM2.5 from NYC and surrounding environs [Meeting Abstract]
Naveed B.; Weiden M.D.; Rom W.N.; Prezant D.J.; Comfort A.; Chen L.; Kwon S.; Chen Y.; Gordon T.; Nolan A.
OBJECTIVES: Particulate matter (PM) exposure causes adverse health effects. The WTC collapse led to significant PM exposure and lung injury (Weiden et al. Chest 2009). The mechanism by which WTC PM causes pulmonary morbidity is not understood. We are investigating the differential cytokine effects on human alveolar cells, comparing ambient PM of WTC to ambient PM from NYC, South Bronx (SB) and Sterling Forest (SF), a rural area northwest of NYC. METHODS AND POPULATION: AM were obtained from Bronchoalveolar lavage (BAL) by adherence overnight. AM were exposed to 50mug/mL suspensions of WTC, SB, and SF PM2.5. Media alone was the negative control and 40 ng/mL of LPS was the positive control. After 24hrs, supernatants were collected and analyzed in duplicate using Human Cytokine Panel I (Millipore) on a Luminex-200. RESULTS: Fold induction of mediators was expressed as ratios of PM exposure/media alone. Exposure to WTC PM was markedly more inflammatory than SB and SF. The most significant inductions were of the leukocyte growth factors (GM-CSF, G-CSF), a promoter of angiogenesis (VEGF), the chemokine (RANTES) and the potent multifunctional cytokine IL-6. LPS caused a greater induction for all of the analytes when compared to WTC PM except for IL-1ra. SIGNIFICANCE OF STUDY: WTC PM2.5 produces a marked inflammatory effect in comparison to PM2.5 from both NYC, SB and rural sites. The large number of cytokines induced by WTC PM may drive airway injury and may be biomarkers for lung injury. WTC PM has been observed in induced sputum obtained 9 months after 9/11/2001 and so the elaboration of cytokines may underlie the severe and long lasting health effects produced by exposure to WTC PM
EMBASE:70206222
ISSN: 1752-8054
CID: 111408
Optical detection of buccal epithelial nanoarchitectural alterations in patients harboring lung cancer: implications for screening
Roy, Hemant K; Subramanian, Hariharan; Damania, Dhwanil; Hensing, Thomas A; Rom, William N; Pass, Harvey I; Ray, Daniel; Rogers, Jeremy D; Bogojevic, Andrej; Shah, Maitri; Kuzniar, Tomasz; Pradhan, Prabhakar; Backman, Vadim
We have recently developed a novel optical technology, partial wave spectroscopic (PWS) microscopy, which is exquisitely sensitive to the nanoarchitectural manifestation of the genetic/epigenetic alterations of field carcinogenesis. Our approach was to screen for lung cancer by assessing the cheek cells based on emerging genetic/epigenetic data which suggests that the buccal epithelium is altered in lung field carcinogenesis. We performed PWS analysis from microscopically normal buccal epithelial brushings from smokers with and without lung cancer (n = 135). The PWS parameter, disorder strength of cell nanoarchitecture (L(d)), was markedly (>50%) elevated in patients harboring lung cancer compared with neoplasia-free smokers. The performance characteristic was excellent with an area under the receiver operator characteristic curve of >0.80 and was equivalent for both disease stage (early versus late) and histologies (small cell versus non-small cell lung cancers). An independent data set validated the findings with only a minimal degradation of performance characteristics. Our results offer proof of concept that buccal PWS may potentially herald a minimally intrusive prescreening test that could be integral to the success of lung cancer population screening programs
PMCID:3703950
PMID: 20924114
ISSN: 1538-7445
CID: 135525